Melanocortin Signaling Crucial for Leptin's Metabolic Benefits in Diabetic Rats

Leptin, a hormone primarily produced by fat cells, plays a critical role in regulating energy balance by signaling satiety to the brain. In conditions like uncontrolled diabetes, leptin resistance often develops, diminishing its ability to control appetite and metabolism. The melanocortin system, particularly the MC4R receptor in the hypothalamus, is a key downstream pathway for leptin's actions. This study aimed to elucidate the specific role of melanocortin signaling in mediating leptin's neuroendocrine and metabolic effects in male rats with uncontrolled diabetes.

Leptin treatment significantly improved metabolic control in diabetic rats. Specifically, leptin alone reduced daily food intake by 28% (p<0.001) and led to an 18% decrease in body weight over the 14-day study period compared to untreated diabetic controls. Blood glucose levels were also profoundly lowered by 35% (p<0.005), alongside a 40% improvement in insulin sensitivity (HOMA-IR). > Pharmacological blockade of melanocortin signaling completely abolished these beneficial effects, with food intake only reduced by 5% and body weight by 3% in the leptin + antagonist group, demonstrating the melanocortin pathway's essential role. Furthermore, leptin increased hypothalamic POMC gene expression by 2.5-fold and decreased AgRP by 1.8-fold, both of which were reversed by the antagonist.